Background: Active surveillance (AS) represents an expectant treatment strategy for clinically localized prostate cancer (PCa) with low-risk features.Objective: The actual management as well as the pros and cons of AS were evaluated.Methods: A systematic review of the recent literature was performed using the Medline databases.